Hong Kong Market Could Open Cash Flood Gates for U.S. Biotechs Hong Kong Market Could Open Cash Flood Gates for U.S. Biotechs

When U.S. biotech startup Sorrento Therapeutics named ex-Lehman Brothers executive Jiong Shao as its new finance chief about two months ago, it was widely seen as a move driven by his background in raising capital for Alibaba and Tencent.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news